An all stock acquisition of DEPO by HZNP should create a PPS for HZNP that is on steroids if it is successful. An additional six new drugs with current annual sales of $400,000,000.00 added to HZNP'S seven current drugs at no monetary cost (only share dilution to shareholders) should create a market cap for the combined company of well over Ten Billion. It appears that Mr Walbert is working overtime for HZNP shareholders.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.